HU-211, A NON-PSYCHOTROPIC CANNABINOID, RESCUES CORTICAL-NEURONS FROM EXCITATORY AMINO-ACID TOXICITY IN CULTURE

被引:58
作者
ESHHAR, N
STRIEM, S
BIEGON, A
机构
[1] Pharmos Limited, Pharmacology Department, KiryatWeizmann, Rehovot
[2] Pharmos Limited, Pharmacology Department, KiryatWeizmann, Rehovot
关键词
CORTICAL CELL CULTURES; NEUROPROTECTION; EXCITOTOXICITY; CANNABINOID; RAT BRAIN; NMDA RECEPTOR; NMDA ANTAGONIST;
D O I
10.1097/00001756-199312000-00013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
THE present study examined potential neuroprotective effects of HU-211, a synthetic non-psychotropic cannabinoid with non-competitive NMDA antagonist properties on neurones exposed to various excitotoxins in culture. HU-211 was found to protect neurones from NMDA and quisqualate-induced toxicity but not that produced by AMPA or kainate. NMDA-mediated neurotoxicity was blocked by HU-211 in a dose dependent manner with an EC(50) = 3.8 +/- 0.9 mu M. Radioligand binding studies have shown that HU-211 inhibits the binding of [H-3]MK-801 to rat forebrain membranes (K-I = 11.0 mu M +/- 1.323) in a competitive manner, but was unable to displace [H-3]kainate and [H-3]AMPA binding. These data suggest that the neuroprotective activity of HU-211 is directly associated with the NMDA receptor channel and possibly with the quisqualate receptor of the metabotropic class. Thus, HU-211 appears to act as an NMDA open channel blocker and shows promise as a novel neuroprotectant for clinical use.
引用
收藏
页码:237 / 240
页数:4
相关论文
共 19 条
  • [1] SELECTIVE ACTIVATION OF QUISQUALATE METABOTROPIC RECEPTOR POTENTIATES NMDA BUT NOT AMPA RESPONSES
    ANIKSZTEJN, L
    BREGESTOVSKI, P
    BENARI, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 205 (03) : 327 - 328
  • [2] BARJOSEOH, 1993, J NEUROCHEM, V61
  • [3] IMMUNOLOGICAL DETECTION OF THE NMDAR1 GLUTAMATE RECEPTOR SUBUNIT EXPRESSED IN HUMAN EMBRYONIC KIDNEY-293 CELLS AND IN RAT-BRAIN
    CHAZOT, PL
    CIK, M
    STEPHENSON, FA
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 59 (03) : 1176 - 1178
  • [4] GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM
    CHOI, DW
    [J]. NEURON, 1988, 1 (08) : 623 - 634
  • [5] A NOVEL PROBE FOR THE CANNABINOID RECEPTOR
    DEVANE, WA
    BREUER, A
    SHESKIN, T
    JARBE, TUC
    EISEN, MS
    MECHOULAM, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (11) : 2065 - 2069
  • [6] KAINYL-BOVINE SERUM-ALBUMIN - A NOVEL LIGAND OF THE KAINATE SUBTYPE OF GLUTAMATE RECEPTOR WITH A VERY HIGH BINDING-AFFINITY
    ESHHAR, N
    LEDERKREMER, G
    BEAUJEAN, M
    GOLDBERG, O
    GREGOR, P
    ORTEGA, A
    TRILLER, A
    TEICHBERG, VI
    [J]. BRAIN RESEARCH, 1989, 476 (01) : 57 - 70
  • [7] NONPSYCHOTROPIC CANNABINOID ACTS AS A FUNCTIONAL N-METHYL-D-ASPARTATE RECEPTOR BLOCKER
    FEIGENBAUM, JJ
    BERGMANN, F
    RICHMOND, SA
    MECHOULAM, R
    NADLER, V
    KLOOG, Y
    SOKOLOVSKY, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) : 9584 - 9587
  • [8] STEREOCHEMICAL EFFECTS OF 11-OH-DELTA-8-TETRAHYDROCANNABINOL-DIMETHYLHEPTYL TO INHIBIT ADENYLATE-CYCLASE AND BIND TO THE CANNABINOID RECEPTOR
    HOWLETT, AC
    CHAMPION, TM
    WILKEN, GH
    MECHOULAM, R
    [J]. NEUROPHARMACOLOGY, 1990, 29 (02) : 161 - 165
  • [9] MAYER ML, 1989, PHYSIOL, V394, P501
  • [10] LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS
    MUNSON, PJ
    RODBARD, D
    [J]. ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) : 220 - 239